BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21942649)

  • 1. Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cells.
    Roche C; Rasolonjanahary R; Thirion S; Goddard I; Fusco A; Figarella-Branger D; Dufour H; Brue T; Franc JL; Enjalbert A; Barlier A
    Hum Gene Ther; 2012 Jan; 23(1):104-14. PubMed ID: 21942649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomas.
    Acunzo J; Thirion S; Roche C; Saveanu A; Gunz G; Germanetti AL; Couderc B; Cohen R; Figarella-Branger D; Dufour H; Brue T; Enjalbert A; Barlier A
    Cancer Res; 2008 Dec; 68(24):10163-70. PubMed ID: 19074883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the pituitary-specific transcription factor pit-1 in somatolactotrope cell growth and death: an approach using dominant-negative pit-1 mutants.
    Pellegrini I; Roche C; Quentien MH; Ferrand M; Gunz G; Thirion S; Bagnis C; Enjalbert A; Franc JL
    Mol Endocrinol; 2006 Dec; 20(12):3212-27. PubMed ID: 16901973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells.
    Cuny T; Zeiller C; Bidlingmaier M; Défilles C; Roche C; Blanchard MP; Theodoropoulou M; Graillon T; Pertuit M; Figarella-Branger D; Enjalbert A; Brue T; Barlier A
    Endocr Relat Cancer; 2016 Jul; 23(7):509-19. PubMed ID: 27267119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary transcription factors: from congenital deficiencies to gene therapy.
    Quentien MH; Barlier A; Franc JL; Pellegrini I; Brue T; Enjalbert A
    J Neuroendocrinol; 2006 Sep; 18(9):633-42. PubMed ID: 16879162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent dual role of PIT-1 (POU1F1) in somatolactotroph cell proliferation and apoptosis.
    Jullien N; Roche C; Brue T; Figarella-Branger D; Graillon T; Barlier A; Herman JP
    PLoS One; 2015; 10(3):e0120010. PubMed ID: 25822178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
    Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
    J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.
    Miyai S; Yoshimura S; Iwasaki Y; Takekoshi S; Lloyd RV; Osamura RY
    Cell Tissue Res; 2005 Nov; 322(2):269-77. PubMed ID: 16133148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pit-1 gene expression in human pituitary adenomas.
    Pellegrini-Bouiller I; Morange-Ramos I; Barlier A; Gunz G; Enjalbert A; Jaquet P
    Horm Res; 1997; 47(4-6):251-8. PubMed ID: 9167960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression.
    Pellegrini-Bouiller I; Morange-Ramos I; Barlier A; Gunz G; Figarella-Branger D; Cortet-Rudelli C; Grisoli F; Jaquet P; Enjalbert A
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3390-6. PubMed ID: 8784102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homeoproteins and pituitary adenoma].
    Barlier A; Pellegrini-Bouiller I; Gunz G; Jaquet P; Enjalbert A
    Ann Endocrinol (Paris); 1997; 58(1):3-10. PubMed ID: 9207961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The R271W mutant form of Pit-1 does not act as a dominant inhibitor of Pit-1 action to activate the promoters of GH and prolactin genes.
    Kishimoto M; Okimura Y; Fumoto M; Iguchi G; Iida K; Kaji H; Chihara K
    Eur J Endocrinol; 2003 Jun; 148(6):619-25. PubMed ID: 12773133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion.
    Zatelli MC; Piccin D; Tagliati F; Ambrosio MR; Margutti A; Padovani R; Scanarini M; Culler MD; degli Uberti EC
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2797-802. PubMed ID: 12788890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters.
    Roche C; Zamora AJ; Taïeb D; Lavaque E; Rasolonjanahary R; Dufour H; Bagnis C; Enjalbert A; Barlier A
    J Endocrinol; 2004 Oct; 183(1):217-33. PubMed ID: 15525589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
    Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
    Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma.
    Ashton C; Rhie SK; Carmichael JD; Zada G
    J Neurosurg; 2020 Feb; 134(3):787-793. PubMed ID: 32109873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
    Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of pituitary-specific gene expression by insulin-like growth factor 1 in rat pituitary GH4C1 and GH3 cells.
    Castillo AI; Aranda A
    Endocrinology; 1997 Dec; 138(12):5442-51. PubMed ID: 9389530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas.
    Asa SL; Puy LA; Lew AM; Sundmark VC; Elsholtz HP
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1275-80. PubMed ID: 8077321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.